Welcome to our dedicated page for iPath® B S&P 500® VIX Md-Trm Futs™ ETN SEC filings (Ticker: VXZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for the iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) focuses on regulatory documents associated with the iPath ETN platform issued by Barclays Bank PLC. Barclays states that each iPath ETN series is governed by a prospectus supplement and a pricing supplement that are filed with the U.S. Securities and Exchange Commission (SEC). These documents set out the detailed terms of each ETN, including index linkage, calculation mechanics, fees, and risk factors.
In its public announcements, Barclays repeatedly directs investors to the applicable prospectus supplement and pricing supplement and to the section titled “Risk Factors” or “Selected Risk Considerations” for a fuller description of the risks associated with its ETNs. The filings explain that iPath ETNs are unsecured debt obligations of Barclays Bank PLC, are not obligations of or guaranteed by any third party, and may result in investors losing some or all of their principal. They also discuss market and volatility risk, liquidity considerations, and the uncertainty surrounding tax treatment.
On Stock Titan, this page aggregates the available SEC filings related to VXZ and the broader iPath ETN program. Real-time updates from the SEC’s EDGAR system allow users to see when new prospectus supplements, pricing supplements, or other registration statements are filed for Barclays’ ETNs. AI-powered summaries help explain the key points of lengthy documents, such as how payment on an ETN is determined, what events can trigger redemption, and which risk factors Barclays emphasizes for that series.
Although no VXZ-specific SEC filings are listed in the materials provided here, the general framework described by Barclays applies to iPath ETNs as a group. Investors can use this page to review historical and newly filed documents for VXZ when they are available, and to understand how Barclays presents credit risk, market risk, and structural features of its ETNs in formal SEC filings.
Barclays Bank PLC has filed a pricing supplement for Barrier Digital Plus Notes linked to the EURO STOXX 50® Index, due June 28, 2027. The notes offer unique investment characteristics compared to traditional debt securities:
Key features include:
- $1,000 minimum denomination
- 11.40% Digital Percentage
- 80% Barrier Value of Initial Underlier Value
- No regular interest payments
- Payment at maturity depends on EURO STOXX 50® Index performance
Investment considerations: If the Final Underlier Value is above the Barrier Value, investors receive principal plus the greater of 11.40% or index return. If below the Barrier Value, investors are fully exposed to index decline. The estimated value ($921.20-$971.20 per $1,000) is less than the issue price, reflecting commissions and costs. Notes include U.K. Bail-in Power provisions, allowing authorities to write-down, convert, or modify the notes under certain circumstances.
Barclays Bank has issued $910,000 in Callable Contingent Coupon Notes due June 24, 2030, linked to the performance of three major indices: Dow Jones Industrial Average, Russell 2000, and S&P 500. The notes offer a potential contingent coupon of $7.25 per $1,000 principal amount (8.70% per annum) if all reference assets close above their respective coupon barrier values on observation dates.
Key features include:
- Minimum denomination of $1,000
- Early redemption option after first six months
- 70% coupon barrier and 50% principal barrier levels
- Risk of up to 100% principal loss if worst-performing index falls below barrier value
Important risks: Notes are subject to Barclays' creditworthiness and U.K. Bail-in Power, which could result in complete loss of investment. The estimated value of $980.30 per note is less than the issue price, with a 0.25% agent commission. Notes will not be listed on any U.S. securities exchange.